Efficacy and Safety of LX9211 in Participants With Postherpetic Neuralgia

PHASE2CompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

December 29, 2020

Primary Completion Date

November 18, 2022

Study Completion Date

December 21, 2022

Conditions
Postherpetic Neuralgia
Interventions
DRUG

Placebo

LX9211 matching-placebo, tablets will be administered orally.

DRUG

LX9211

LX9211, 200 mg, tablets will be administered orally.

Trial Locations (32)

12000

Lexicon Investigational Site (137), Prague

13000

Lexicon Investigational Site (141), Prague

16000

Lexicon Investigational Site (135), Prague

19046

Lexicon Investigational Site, Jenkintown

27518

Lexicon Investigational Site (148), Cary

30060

Lexicon Investigational Site (147), Marietta

32174

Lexicon Investigational Site, Ormond Beach

32789

Lexicon Investigational Site, Winter Park

33032

Lexicon Investigational Site (113), Miami

33144

Lexicon Investigational Site, Miami

33174

Lexicon Investigational Site, Miami

33511

Lexicon Investigational Site, Brandon

48187

Lexicon Investigational Site, Canton

53002

Lexicon Investigational Site (140), Pardubice

53144

Lexicon Investigational Site, Kenosha

60084

Lexicon Investigational Site, Wauconda

60422

Lexicon Investigational Site, Flossmoor

63042

Lexicon Investigational Site, Hazelwood

77521

Lexicon Investigational Site, Baytown

77901

Lexicon Investigational Site, Victoria

84102

Lexicon Investigational Site, Salt Lake City

85258

Lexicon Investigational Site, Scottsdale

85741

Lexicon Investigational Site, Tucson

87102

Lexicon Investigational Site, Albuquerque

94904

Lexicon Investigational Site, Greenbrae

02131

Lexicon Investigational Site, Boston

565 01

Lexicon Investigational Site (138), Choceň

100 00 00

Lexicon Investigational Site (136), Prague

40-282

Lexicon Investigational Site (128), Katowice

640-748

Lexicon Investigational Site (130), Katowice

20-064

Lexicon Investigational Site (134), Lublin

01-868

Lexicon Investigational Site (133), Warsaw

Sponsors
All Listed Sponsors
lead

Lexicon Pharmaceuticals

INDUSTRY